Manufacturers Life Insurance Company, The Collegium Pharmaceutical, Inc Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 14,840 shares of COLL stock, worth $445,942. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,840
Previous 15,151
2.05%
Holding current value
$445,942
Previous $585,000
27.35%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding COLL
# of Institutions
247Shares Held
37.4MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$174 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$79.3 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$70.6 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$68.6 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$64.4 Million0.15% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.03B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...